Find a medicine
Search by molecule, brand or therapy area. Add what you need to your requirement list, set quantities, and send it to our team in one go.
“” isn’t in our reference list, but we source many products on request.
| Molecule | Class | Therapy area | Typical storage | Action |
|---|---|---|---|---|
| Atezolizumab | PD-L1 checkpoint inhibitor | Oncology | 2–8 °C | |
| Azacitidine | Hypomethylating agent | Oncology | Room temp. | |
| Bevacizumab | Anti-VEGF monoclonal antibody | Oncology | 2–8 °C | |
| Bortezomib | Proteasome inhibitor | Oncology | Room temp. | |
| Calcium folinate (leucovorin) | Folate rescue | Oncology | Room temp. | |
| Capecitabine | Oral fluoropyrimidine | Oncology | Room temp. | |
| Carboplatin | Platinum chemotherapy | Oncology | Room temp. | |
| Cetuximab | Anti-EGFR monoclonal antibody | Oncology | 2–8 °C | |
| Cisplatin | Platinum chemotherapy | Oncology | Room temp. | |
| Cyclophosphamide | Alkylating agent | Oncology | Room temp. | |
| Daratumumab | Anti-CD38 monoclonal antibody | Oncology | 2–8 °C | |
| Denosumab | RANKL monoclonal antibody | Oncology | 2–8 °C | |
| Docetaxel | Taxane chemotherapy | Oncology | Varies by brand | |
| Doxorubicin | Anthracycline | Oncology | Varies by brand | |
| Durvalumab | PD-L1 checkpoint inhibitor | Oncology | 2–8 °C | |
| Everolimus | mTOR inhibitor | Oncology | Room temp. | |
| Filgrastim | G-CSF | Oncology | 2–8 °C | |
| Fluorouracil (5-FU) | Antimetabolite | Oncology | Room temp. | |
| Fosaprepitant | NK1 antiemetic | Oncology | 2–8 °C | |
| Fulvestrant | Oestrogen-receptor degrader | Oncology | 2–8 °C | |
| Gefitinib | EGFR tyrosine kinase inhibitor | Oncology | Room temp. | |
| Gemcitabine | Antimetabolite | Oncology | Room temp. | |
| Goserelin | LHRH agonist implant | Oncology | Room temp. | |
| Imatinib | Tyrosine kinase inhibitor | Oncology | Room temp. | |
| Lenalidomide | Immunomodulator | Oncology | Room temp. | |
| Letrozole | Aromatase inhibitor | Oncology | Room temp. | |
| Mesna | Uroprotectant | Oncology | Room temp. | |
| Nivolumab | PD-1 checkpoint inhibitor | Oncology | 2–8 °C | |
| Olaparib | PARP inhibitor | Oncology | Room temp. | |
| Osimertinib | EGFR tyrosine kinase inhibitor | Oncology | Room temp. | |
| Oxaliplatin | Platinum chemotherapy | Oncology | Room temp. | |
| Paclitaxel | Taxane chemotherapy | Oncology | Room temp. | |
| Palbociclib | CDK4/6 inhibitor | Oncology | Room temp. | |
| Palonosetron | 5-HT3 antiemetic | Oncology | Room temp. | |
| Pegfilgrastim | Long-acting G-CSF | Oncology | 2–8 °C | |
| Pembrolizumab | PD-1 checkpoint inhibitor | Oncology | 2–8 °C | |
| Pemetrexed | Antifolate | Oncology | Room temp. | |
| Pertuzumab | HER2 monoclonal antibody | Oncology | 2–8 °C | |
| Pomalidomide | Immunomodulator | Oncology | Room temp. | |
| Ribociclib | CDK4/6 inhibitor | Oncology | Room temp. | |
| Rituximab | Anti-CD20 monoclonal antibody | Oncology | 2–8 °C | |
| Temozolomide | Oral alkylating agent | Oncology | Room temp. | |
| Trastuzumab | HER2 monoclonal antibody | Oncology | 2–8 °C | |
| Trastuzumab emtansine | Antibody–drug conjugate | Oncology | 2–8 °C | |
| Zoledronic acid | Bisphosphonate | Oncology | Room temp. | |
| Anti-thymocyte globulin | Induction / rejection therapy | Nephrology | 2–8 °C | |
| Basiliximab | Anti-CD25 induction antibody | Nephrology | 2–8 °C | |
| Calcitriol | Active vitamin D | Nephrology | Room temp. | |
| Cinacalcet | Calcimimetic | Nephrology | Room temp. | |
| Cyclosporine | Calcineurin inhibitor | Nephrology | Room temp. | |
| Darbepoetin alfa | Erythropoiesis-stimulating agent | Nephrology | 2–8 °C | |
| Erythropoietin (epoetin) | Erythropoiesis-stimulating agent | Nephrology | 2–8 °C | |
| Ferric carboxymaltose | Intravenous iron | Nephrology | Room temp. | |
| Iron sucrose | Intravenous iron | Nephrology | Room temp. | |
| Mycophenolate mofetil | Antiproliferative immunosuppressant | Nephrology | Room temp. | |
| Mycophenolate sodium | Antiproliferative immunosuppressant | Nephrology | Room temp. | |
| Sevelamer | Phosphate binder | Nephrology | Room temp. | |
| Sirolimus | mTOR inhibitor | Nephrology | Room temp. | |
| Tacrolimus | Calcineurin inhibitor | Nephrology | Room temp. | |
| Valganciclovir | Antiviral (CMV) | Nephrology | Room temp. | |
| Abiraterone acetate | Androgen synthesis inhibitor | Urology | Room temp. | |
| Apalutamide | Androgen-receptor inhibitor | Urology | Room temp. | |
| BCG (intravesical) | Intravesical immunotherapy | Urology | 2–8 °C | |
| Degarelix | GnRH antagonist | Urology | Room temp. | |
| Dutasteride | 5-alpha-reductase inhibitor | Urology | Room temp. | |
| Enzalutamide | Androgen-receptor inhibitor | Urology | Room temp. | |
| Leuprolide | LHRH agonist depot | Urology | Varies by brand | |
| Mirabegron | Beta-3 agonist | Urology | Room temp. | |
| Mitomycin (intravesical) | Intravesical chemotherapy | Urology | Room temp. | |
| Solifenacin | Antimuscarinic | Urology | Room temp. | |
| Tamsulosin | Alpha-blocker | Urology | Room temp. | |
| Abacavir | Nucleoside reverse transcriptase inhibitor | HIV | Room temp. | |
| Atazanavir + ritonavir | Boosted protease inhibitor | HIV | Room temp. | |
| Darunavir | Protease inhibitor | HIV | Room temp. | |
| Dolutegravir | Integrase inhibitor | HIV | Room temp. | |
| Efavirenz | Non-nucleoside reverse transcriptase inhibitor | HIV | Room temp. | |
| Emtricitabine + tenofovir | NRTI combination | HIV | Room temp. | |
| Lamivudine | Nucleoside reverse transcriptase inhibitor | HIV | Room temp. | |
| Lopinavir + ritonavir | Boosted protease inhibitor | HIV | Room temp. | |
| Tenofovir + lamivudine + dolutegravir (TLD) | Fixed-dose ART combination | HIV | Room temp. | |
| Tenofovir alafenamide | Nucleotide reverse transcriptase inhibitor | HIV | Room temp. | |
| Tenofovir disoproxil fumarate | Nucleotide reverse transcriptase inhibitor | HIV | Room temp. | |
| Zidovudine | Nucleoside reverse transcriptase inhibitor | HIV | Room temp. | |
| Anidulafungin | Echinocandin antifungal | Critical care | 2–8 °C | |
| Atracurium | Neuromuscular blocker | Critical care | 2–8 °C | |
| Caspofungin | Echinocandin antifungal | Critical care | 2–8 °C | |
| Ceftazidime + avibactam | Beta-lactam / beta-lactamase inhibitor | Critical care | Room temp. | |
| Colistimethate sodium (colistin) | Polymyxin antibiotic | Critical care | Room temp. | |
| Dexmedetomidine | Sedative | Critical care | Room temp. | |
| Enoxaparin | Low-molecular-weight heparin | Critical care | Room temp. | |
| Human albumin | Plasma-derived protein | Critical care | Varies by brand | |
| Imipenem + cilastatin | Carbapenem antibiotic | Critical care | Room temp. | |
| Intravenous immunoglobulin (IVIG) | Plasma-derived immunoglobulin | Critical care | Varies by brand | |
| Linezolid | Oxazolidinone antibiotic | Critical care | Room temp. | |
| Liposomal amphotericin B | Polyene antifungal | Critical care | Room temp. | |
| Meropenem | Carbapenem antibiotic | Critical care | Room temp. | |
| Micafungin | Echinocandin antifungal | Critical care | Room temp. | |
| Noradrenaline | Vasopressor | Critical care | Room temp. | |
| Polymyxin B | Polymyxin antibiotic | Critical care | 2–8 °C | |
| Posaconazole | Triazole antifungal | Critical care | Room temp. | |
| Rocuronium | Neuromuscular blocker | Critical care | 2–8 °C | |
| Teicoplanin | Glycopeptide antibiotic | Critical care | Room temp. | |
| Tigecycline | Glycylcycline antibiotic | Critical care | Room temp. | |
| Vancomycin | Glycopeptide antibiotic | Critical care | Room temp. | |
| Vasopressin | Vasopressor | Critical care | Varies by brand | |
| Voriconazole | Triazole antifungal | Critical care | Room temp. | |
| Hepatitis A vaccine | Vaccine | Vaccines | 2–8 °C | |
| Hepatitis B immunoglobulin | Immunoglobulin | Vaccines | 2–8 °C | |
| Hepatitis B vaccine | Vaccine | Vaccines | 2–8 °C | |
| HPV vaccine | Vaccine | Vaccines | 2–8 °C | |
| Human rabies immunoglobulin | Immunoglobulin | Vaccines | 2–8 °C | |
| Influenza vaccine | Vaccine | Vaccines | 2–8 °C | |
| Meningococcal conjugate vaccine | Vaccine | Vaccines | 2–8 °C | |
| Pneumococcal conjugate vaccine | Vaccine | Vaccines | 2–8 °C | |
| Rabies monoclonal antibody | Monoclonal antibody | Vaccines | 2–8 °C | |
| Rabies vaccine (cell culture) | Vaccine | Vaccines | 2–8 °C | |
| Tdap vaccine | Vaccine | Vaccines | 2–8 °C | |
| Tetanus & diphtheria (Td) vaccine | Vaccine | Vaccines | 2–8 °C | |
| Typhoid conjugate vaccine | Vaccine | Vaccines | 2–8 °C | |
| Varicella vaccine | Vaccine | Vaccines | 2–8 °C | |
| Yellow fever vaccine | Vaccine | Vaccines | 2–8 °C | |
| Aflibercept | Anti-VEGF intravitreal injection | Retina | 2–8 °C | |
| Brolucizumab | Anti-VEGF intravitreal injection | Retina | 2–8 °C | |
| Dexamethasone intravitreal implant | Intravitreal corticosteroid | Retina | Room temp. | |
| Faricimab | Anti-VEGF / Ang-2 intravitreal injection | Retina | 2–8 °C | |
| Ranibizumab | Anti-VEGF intravitreal injection | Retina | 2–8 °C | |
| Triamcinolone (intravitreal) | Intravitreal corticosteroid | Retina | Room temp. | |
| Cetrorelix | GnRH antagonist | Fertility (IVF) | 2–8 °C | |
| Choriogonadotropin alfa | Recombinant hCG | Fertility (IVF) | 2–8 °C | |
| Follitropin alfa | Recombinant FSH | Fertility (IVF) | 2–8 °C | |
| Ganirelix | GnRH antagonist | Fertility (IVF) | Varies by brand | |
| Menotropin (hMG) | Gonadotropin | Fertility (IVF) | Varies by brand | |
| Progesterone | Luteal-phase support | Fertility (IVF) | Room temp. | |
| Insulin degludec | Long-acting insulin | Metabolic | 2–8 °C | |
| Insulin glargine | Long-acting insulin | Metabolic | 2–8 °C | |
| Liraglutide | GLP-1 receptor agonist | Metabolic | 2–8 °C | |
| Semaglutide | GLP-1 receptor agonist | Metabolic | 2–8 °C | |
| Tirzepatide | GIP / GLP-1 receptor agonist | Metabolic | 2–8 °C |
This is a reference list of molecules commonly requested from us, not a live stock list. Most are available in more than one brand. Storage shown is typical for the molecule — always follow the product label. Brand names are trademarks of their owners and are used only to help you find the molecule. Prescription medicines are supplied only to licensed buyers or against a valid prescription.